I am personally interested in the pharmaceutical industry. I once invested in an active fund, 1 drug. After two years of persistence, I thought it was an anti-risk product, but the drug component of this fund only accounted for less than 50%, which did not meet my expectations. Later, I made a decisive move. At a time when the stock market valuation is killing, I am going to start investing in medical index funds.
Why do you have a soft spot for the pharmaceutical industry?
At present, China's national conditions will promote the long-term stable growth of the pharmaceutical industry. At present, China is gradually aging, and the disease probability and medical needs of the elderly population are significantly higher than those of other age groups. According to statistics, the number of elderly people over 60 has reached 230 million, accounting for16.7% of the total population; The population over 65 years old reached 65.438+0.5 billion, accounting for 654.38+0.8% of the total population. It is estimated that by 2050, the proportion of the elderly population in China will exceed 30%. The continuous increase of the elderly population is the first driving force to promote the steady growth of the pharmaceutical industry. First, the aging of China promotes the growth of the pharmaceutical industry.
Second, seeking medical treatment is a rigid demand of residents. Everyone can't live without birth, illness and death. Everyone will get sick, and when they get sick, they will go to the doctor to take medicine. This is the rigid demand of residents, and this demand will not be reduced due to economic depression, natural disasters and other reasons.
The third is the practice test of Chinese and foreign medical indicators. In most countries, the pharmaceutical industry is a good industry for decades. Medical index is a very valuable hedging tool in the economic crisis. Even if the macro-economy is not good, the overall performance of the pharmaceutical industry is better than the macro-economy.
From the Japanese stock market, from 1992 to 20 12, the Nikkei index fell by 25.6% and the pharmaceutical index rose by 92%. From the US stock market, from September 1989 to July 20 14, the S&P 500 index rose by 465%, and the S&P 500 pharmaceutical index rose by 969% in the same period. The growth rate of the pharmaceutical industry was more than twice that of the S&P 500. According to the data of A-shares, it is assumed that 1 000 yuan will be invested in the pharmaceutical industry at the end of 2004, and by May 20 1007, the initial investment of 1 000 yuan will become 9383 yuan, with a return of more than 9 times.
What are the medical indicators to choose from?
At present, there are seven kinds of medical indexes in the market for us to screen, namely, CSI medical index, CSI medical index 100, SSE medical index, full index medical index, subdivided medical index, 300 medical index and 500 medical index.
CSI Pharmaceutical Index: Also known as CSI 800 Pharmaceutical Index, the pharmaceutical industry is selected from CSI 800 Index.
CSI Medicine 100 Index: Select the top 100 stocks in medical and health-related industries from Shanghai and Shenzhen A-shares, and each stock has the same purchase amount. The base date is 65438+February 3, 20041,and the base point is 1000.
Shanghai stock exchange medical index: only invest in the medical and health industry of Shanghai stock exchange.
All-index pharmaceutical index: select stocks with good liquidity and strong market representation from the sample stocks in the medical and health industry, which cover the most comprehensive pharmaceutical companies.
Sub-pharmaceutical index: select major companies in sub-sectors of pharmaceutical industry.
300 Pharmaceutical Index: Select pharmaceutical companies in the Shanghai and Shenzhen 300 Index.
500 Pharmaceutical Index: Select the pharmaceutical companies in the CSI 500 Index.
From the historical data, among the seven major medical indexes, CSI Medicine Index, CSI Medicine 100 Index and Quanzhi Medicine have certain influence and good liquidity. The trend since 20-200517 and 12 shows that the best performance is CSI Medicine 100 index, and 12.5 has increased by 1 1.7 times, far ahead of Shanghai and Shenzhen 300 and dividend index.
Which medical index fund should I choose?
Individuals will consider choosing CSI 100 index.
First, the sample selection method of CSI Medicine 100 index is scientific. Take all A shares (non-ST and *ST shares) in Shanghai and Shenzhen stock markets as the sample space. The sample selection method, first of all, will be in the sample space in the past year, the average daily turnover of A shares in Shanghai and Shenzhen stock markets (non-st, *ST shares) after 20% of the stock out; Secondly, the remaining stocks will be included in the medical theme according to the industry classification standard of CSI. Finally, the sample stocks of CSI Medicine 100 Index are composed of the stocks with the top average daily market value of 100 in the past year.
Second, the valuation of CSI Medicine 100 index is reasonable. The current P/E ratio of medicine 100 index is 33.48, the P/B ratio is 4.43, the dividend yield is 0.73%, and the ROE is 13.22%. Although not underestimated, it is still in a reasonable space. Judging from the historical PE trend, the valuation of the pharmaceutical 100 index hovers between 30 and 40 all the year round, which means that the valuation has not changed much and the stock price has already risen to the sky. This also reflects the excellent growth of the pharmaceutical sector from the side.
Third, the heavyweights of CSI Medicine 100 index are basically the leaders of the pharmaceutical industry. Its heavyweight stocks include Tiger Medicine, Weining Health, Kangtai Bio, Changsheng Bio, Pien Tze Huang, Lepu Medical, Aier Ophthalmology, Tongce Medical, Kailaiying, Antu Bio and so on. Most of these heavyweights are leading enterprises in the industry that we often hear about.
From the historical data, the pharmaceutical 100 index is ten times that of ten years, and the index market dominated by leading enterprises in this industry is willing to give a bigger premium. At present, there are two funds tracking the CSI 100 medical index in the market, namely the CSI 100 index of the League of Nations (00059) and the CSI 100 index of Tian Hong (001550/0015565438).
Guolian 'an Zhongzheng Pharmaceutical Co., Ltd. 100(000059) was purchased off-site, and was established on August 20th13. The fund scale is 1 6.87 million yuan, which has increased by 5.89% every year and 56.78% since its establishment.
Tian Hong Zhongzheng Pharmaceutical Co., Ltd. 100(00 1550) was established on June 20 15 for off-site subscription. The scale of the fund is 654.38+25 million yuan, with an increase of 9.29% in 1 year and-19.52% since its establishment.
Comparing the two products, I will choose Guolian 'an Zhongzheng Pharmaceutical Co., Ltd. 100(000059) as the fixed investment target, and make fixed investment regularly.